Why Medical Device Design Transfer Fails: What Breaks Before Transfer Begins

Why Medical Device Design Transfer Fails: What Breaks Before Transfer Begins

Design Transfer Failures in Medical Devices: Strategic Risk Mitigation

Design Transfer rarely fails at the moment of transfer itself. By the time a team reaches that stage, the outcome is already largely determined. What appears to be a breakdown at transfer is the first visible sign of misalignment built into the system much earlier, while the interfaces between design, manufacturing, and quality were still undefined or unstable.

Across programs, the same patterns appear. Incomplete traceability between design inputs and manufacturing outputs. Validation executed before manufacturing processes were stable. Supplier capability assumed instead of proven. Transfer is where those gaps turn into schedule slip and rework.

When transfer stalls, the recovery cost is not small. Programs that hit traceability or process validation gaps at this stage typically absorb four to ten weeks of slip before the first corrective action closes. Regulatory submissions get delayed. Re-V&V cycles open. Design changes get introduced under timeline pressure without adequate change control, which compounds the original problem.

Where Transfer Actually Breaks

Design Transfer is the moment where design intent must survive execution across multiple teams, systems, and real production constraints. The Design History File exists. Manufacturing procedures are defined. Acceptance criteria are documented and approved. But manufacturing cannot execute that documentation without interpretation, and processes that look complete on paper were not designed to operate together under real timelines.

Teams begin operating from slightly different versions of the same system. By the time that becomes visible, it is no longer an isolated problem.

Four Patterns That Show Up Across Programs

The DHF does not hold the system together


Most organizations assume the Design History File is complete because all required documents are present. The more critical issue is fragmentation. Design decisions live in engineering tools. Manufacturing constraints live in separate procedures. Quality requirements are documented independently. Each element is technically correct, but the system cannot be reconstructed from it.
When problems surface during validation or early production, teams reconstruct the rationale behind decisions rather than troubleshoot the product. What should be a clear path from the Design History File to the Device Master Record becomes a forensic exercise. That slows resolution and introduces additional risk when timelines are already constrained.

Validation closes before manufacturing processes are stable


Validation confirms the product meets requirements. It does not confirm it can be manufactured consistently. Validation closes before manufacturing processes are fully developed because that is how the work is sequenced.
Designs that perform under controlled conditions encounter variability when exposed to real production. Teams adapt processes to fit a fixed design instead of refining the design against process capability. Rework increases. Delays compound.

Supplier capability is assumed long before it is proven


Supplier failures come from assumptions made early about what suppliers can deliver. Teams proceed with confidence that requirements are understood and achievable, without validating measurement systems, process stability, or performance at scale.
Initial samples meet specifications because they are produced under controlled, non-representative conditions. Variability emerges during sustained production. At that point, issues are hard to isolate because the system was never proven at scale. What looks like a supplier problem is a gap in how the system qualified itself.

Change control does not propagate across functions


Most organizations have defined change control procedures. Few have systems that maintain alignment across all functions in real time. Design updates and labeling revisions do not propagate consistently across manufacturing, quality, and downstream documentation.
Labeling does not reflect the latest approved version. Risk documentation lags behind design updates. Manufacturing continues on previous assumptions. These are not isolated errors. They are a system that is no longer synchronized.

Why These Failures Surface Late


By the time a program reaches verification, validation, or transfer, these issues are no longer hidden. They appear as broken traceability, inconsistent validation evidence, and misalignment between design, manufacturing, and quality functions.
By this point, the system is no longer being evaluated. It is failing under real conditions.
Regulators are not checking for document presence. They are testing whether traceability, validation, and change control hold under scrutiny. When alignment is missing, that consistency cannot be demonstrated, even when individual components of the system appear complete.

What Teams That Get Through Transfer Cleanly Do Differently


Programs that move through transfer without significant disruption share a few traits:

  • Design, manufacturing, and quality operate from the same traceable system from the start, not from parallel documentation reconciled later.
  • Validation is scoped against real production conditions, including process variability, supplier tolerances, and manufacturing environment, not just functional performance.
  • Supplier qualification is treated as a system verification activity, not a procurement step.


Transfer does not introduce risk. It exposes whether the system was ever stable.

How Nectar Engages at This Stage


When we come in at or before transfer, we focus on three things: where the DHF breaks against the current manufacturing baseline, whether validation evidence reflects actual process capability, and where change control has drifted between the design record and the Device Master Record. The output is a gap assessment with a prioritized remediation path, specific enough to execute against.
If any of these patterns are present as you approach transfer, the system is already under strain. That is the point to address it, not after validation fails or production starts slipping. If that is where your program is, we can walk through where your system breaks before transfer begins.

Post New Nectar logo building
LEARN MORE ABOUT US
Nectar is an award-winning design & engineering consultancy with a specialization in medical device development. We are proudly 13485 certified, we adhere to the highest industry standards. Nectar has been an industry leader in Southern California for over 25 years. Our proven user-centered design process has facilitated the successful launch of hundreds of products in the market.
Nectar logo color
SIGN UP FOR THE NEWSLETTER

The news you need to stay on top of cutting edge medical product development.

By subscribing, you acknowledge and agree to Nectar’s Terms of Use and Privacy Policy.

FAQs

How can organizations objectively determine whether their Design History File (DHF) is structurally capable of supporting Design Transfer?

A complete DHF does not guarantee a transferable system. The determining factor is whether the DHF can be used to reconstruct the full design-to-manufacturing logic without external interpretation. This requires continuous traceability between design inputs, outputs, risk controls, verification evidence, and manufacturing specifications. If teams must interpret intent, reconcile disconnected documents, or reverse-engineer decisions during transfer, the DHF is not functioning as a system of record but as a document repository – an early indicator of transfer failure risk.

Why does successful verification and validation (V&V) not necessarily indicate readiness for Design Transfer in medical device programs?

Verification and validation confirm that a device meets defined requirements under controlled conditions, but they do not inherently validate manufacturing system robustness. Transfer readiness depends on whether those results hold under real production variability – across operators, environments, and supplier inputs. Programs that decouple V&V from process capability often pass validation yet fail during transfer, as the system was never tested as an integrated, production-representative environment.

What systemic indicators suggest that Design Transfer risks are already embedded before the transfer phase begins?

Transfer risks are typically visible long before formal transfer activities start. Indicators include fragmented traceability across systems, validation executed prior to manufacturing maturity, unverified supplier assumptions, and inconsistent change propagation between design and production documentation. These are not isolated issues but signals of a misaligned system. By the time transfer begins, these misalignments manifest as execution failures, rework cycles, and regulatory exposure, rather than discrete, correctable gaps.

Nectar logo color

We are an ISO 13485-certified design and engineering firm based in Southern California, specializing in the development of cutting-edge medical devices.

Our Services
Mechanical engineering, Industrial Design, Software
Firmware, Usability, User interface design, Regulatory

Acumen IQ device in use

Related Blogs

Nectar’s Medical Device Key Factor: Design Thinking

Design Thinking is a methodology that was made famous by Stanford School, and focuses on user input to drive the design and solve problems. Read to know more.

Read Now

Innovative Ventilator Design: Nectar’s BreathDirect BDR-19 Unveiled

Incorporate a user-interface design strategy ensures that all of your products meet all user needs and fulfill the intentional purposes required by the FDA.

Read Now

The Basics of User-Centered Design for Products Success

A great idea combined with great design skills are not good enough to guarantee your product’s. See why the design process starts with end-users in mind.

Read Now
image 65

Darren Saravis

CEO

Darren is an accomplished, dynamic leader who founded Nectar, X-Naut, and BreathDirect. He is committed to improving the world through the synthesis of technology, science, and art. Under Darren’s leadership, Nectar is leveraging the latest advances in cutting-edge technology to transform medical device development and design. As part of his

image 65 (3)

John Duval

Principal Engineer

John is a true asset to Nectar, having been a founding member and instrumental in shaping the company’s portfolio and establishing its reputation for engineering excellence. With over 30 patents and numerous design awards to his name, John is a master of product architecture and subsystem integration, as well as design for manufacture, mechanisms, and root cause analysis. His passion for creating simple and holistic solutions that take into account a wide range of variables is evident in his work and has made him a valuable member of the Nectar team.

Stefanie Ng

Regulatory & Quality Expert

Stefanie brings over 10 years of experience in regulatory affairs and quality assurance, guiding a wide range of medical devices and pharmaceutical products through complex global requirements. She has successfully managed FDA 483 responses, 510(k) submissions, and audits across U.S., EU, APAC, and LATAM markets. Known for her collaborative and solutions-driven approach, Stefanie helps both startups and established companies navigate evolving regulatory landscapes with creative, compliant strategies.

Bryan Chan

Senior AI and Software Architect

Bryan Chan is a Senior AI and Software Architect with extensive experience in developing AI-driven medical technologies that are both innovative and compliant with industry standards (ISO 62304). His accomplishments include leading the development of: an AI-powered, contactless remote patient monitoring device with LLM-based voice engagement, a closed-loop insulin pump for Type 2 diabetes using on-body sensors, a motorized smart walker with real-time gait analysis, and an FDA-compliant AI SaMD platform for gastrointestinal disease detection. Bryan excels at defining technical vision, building high-performance teams, and navigating complex regulatory pathways to deliver scalable, market-ready MedTech solutions.

image 65 (6)

Adam Marten

Senior Mechanical Engineer

Adam Marten has worked in the aerospace and consumer products industries since 2006 with lead engineering experience in conceptual design, product development, analysis and performance qualification testing. Adam has experience leading a range of technical projects, including multiple structural analyses for military and aerospace applications. He has also worked directly with engineering teams to develop medical devices and laboratory instrumentation.

image 65 (7)

James Wilkin

Design & Usability Manager

James is a seasoned professional with over seven years of experience at Nectar, where he brings his expertise in industrial design, user interface, and user experience to the table. With a background in the highly competitive automotive industry, working for heavyweights like Daimler and Tesla, James is a true asset to the Nectar team. He is responsible for ensuring that the company adheres to user-centered design best practices, and he works closely with clients and partners on crucial human factors strategies for FDA submissions and the overall usability engineering process. James’ achievements in this field speak to his exceptional skills and dedication to the work he does.

image 65 (9)

Belen Quintero

Associate Project Manager

Belen is a project manager at Nectar who brings a wealth of experience and expertise to her role. With a strong background in Mathematics and Philosophy from the University of California, Riverside, she has honed her skills in a variety of industries including healthcare ,education, food manufacturing, and engineering. Belen’ success as a project manager is due in large part to her ability to align projects with business goals, clearly define project needs, lead cross-functional teams, and effectively communicate results to stakeholders. With her proven track record of success, Belen is a valuable asset to the Nectar team and a key player in driving the company’s projects forward.
image 65 (10)

Erjon Ameti

Mechatronics Engineer

Erjon Ameti is a highly knowledgeable Mechatronics Engineer with a wealth of experience in both academic settings and startup environments. With a strong background in electronics, robotics, and 3D modeling, he possesses a unique combination of skills that allow him to excel in the fields of automation systems and mechatronics. Over the past five years, Erjon has honed his expertise in product development and industrial automation, emerging as a leading authority in his field. Currently, Erjon works at Nectar as a hardware engineer, where he is responsible for documentation, CAD design, and electronics in general. He has been involved in the entire process of Nectar engineering, bringing his expertise and experience to the forefront of the company’s success.
image 65 (11)

Redon Berisha

Electronics Engineer

Redon is a highly skilled engineer with a passion for technology and innovation. He has a background in mechatronics, which has given him a strong foundation in electronics, including electronic design, PCB design, and cable design. Redon excels in the critical components of the design process, including documentation for assemblies, testing, debugging, and ensuring each project is completed to the highest standard. At Nectar, he plays a crucial role in the creation of cutting-edge technology, bringing his unique vision to life and making him a valuable member of the team. With his technical expertise and creative vision, Redon is a leader in the field of electronic design.
image 65 (12)

Kerry Eiss

Clinical Expert - RN, BSN, CLNC

With over two decades of experience in healthcare innovation, Kerry has been instrumental in transforming patient care and improving patient outcomes across the globe. Her extensive knowledge and expertise in the cardiovascular and cardiothoracic operating room, as well as her experience in emergency medicine, geriatrics, pediatric psychiatry, and main OR, make her a versatile and valuable member of the team. From small hospitals to large teaching institutions, Kerry’s 20 years of experience with patient documentation, including the use of EPIC, Cerner, and Meditech electronic charting systems, have positioned her as a leader in her field. Her recent involvement in helping transition the Providence St. Vincent Medical Center’s Cardiac Surgery program from paper charting to electronic documentation further underscores her commitment to advancing the healthcare industry.

image 65 (13)

Flaka Brahimi

Marketing Manager

Flaka, a highly skilled professional with a background in Architecture and Spatial Planning from the University of Business and Technology in Pristina, holds a dual role at Nectar as both the Marketing Project Manager and a valuable member of the Business Development team. In her role as Marketing Project Manager, she is responsible for overseeing the development and execution of marketing strategies and as a member of the Business Development team, she actively contributes to the growth of the company by assisting in the creation of impactful marketing tactics. With her diverse background and expertise, Flaka plays a crucial role in ensuring the success of Nectar’s projects.
image 65 (14)

Brayton Hammerli

User Experience Designer

Brayton is a multi-disciplinary designer with a A.A in Studio Arts and a B.S in Industrial Design from California State University Long Beach. As a user experience designer, Brayton specializes in usability evaluations, user research, feedback studies, GUI design, mobile app design, human factors evaluations, and formative studies. In his free time, Brayton enjoys outdoor activities such as hiking, mountain biking as well as other creative pursuits. He approaches problems with a solution-focused mindset and enjoys exploring ideas. 
image 65 (16)

Toska Ukaj

Scientific Content Writer

Toska Ukaj is a gifted writer who brings a wealth of expertise and passion to Nectar. With a background in medical science and years of experience producing high-quality scientific and medical publications, Toska’s writing skills are unparalleled. She boasts an excellent educational record, advanced interpersonal skills, and a deep passion for healthcare. As Nectar’s writer, Toska consistently produces clear, concise pieces that can be easily understood by the public and truly captures the essence of Nectar’s mission. With her exceptional writing abilities and commitment to healthcare, Toska is an invaluable asset to the Nectar team.
image 65 (18)

Jonathan Cantera

Human Factors Engineer

Jonathan is a Human Factors Engineer with a background in psychology and sociology, bringing a unique perspective that bridges human behavior, usability, and inclusive design. Grounded in universal design principles, his work focuses on creating safe, accessible, and intuitive user experiences informed by both qualitative and quantitative research. At Nectar, Jonathan leads the Human Factors team, guiding research and risk management efforts through user testing, field studies, and evidence-based evaluations to ensure that every product decision reflects the real needs of its users.

Vesa Hyseni

Purchasing Manager

Vesa is a skilled Purchasing Manager with a strong focus on procurement strategies and vendor management. With a track record of successfully leading procurement teams, Vesa excels in optimizing procurement processes, consistently striking a balance between quality assurance and cost-effectiveness. Her ability to identify cost-saving opportunities and manage supplier relationships effectively makes her an indispensable asset to Nectar.

Uran Çabra

Software Engineer

Uran Çabra, with a background in Mechatronic Systems Engineering, has been working on Embedded Systems, specifically on IoT product development. His responsibilities include firmware development and electronics design and testing. He holds a master’s degree in Electrical Engineering with a focus on Autonomous Mobile Robotics.

Sarah Clark

Industrial Designer

Sarah has a background in fine art & graphic design with a B.S in Industrial Design from California State University Long Beach. As a user experience designer her specialties include: keen aesthetics, creative problem solving, a detail oriented approach to research, and improving user journeys within complex experiences.

Jenny Tran

Human Factors Engineer

Jenny is a Human Factors Engineer with a strong foundation in psychology, bringing a research-driven approach to usability, workflow analysis, and user-centered design. She has worked across clinical, consumer, and emerging technology spaces, leading studies that examine cognitive workload, fatigue, task performance, and product interaction to optimize safety and usability. At Nectar, Jenny collaborates with cross-functional teams to translate user needs into actionable design recommendations, supporting risk management, formative evaluations, and usability strategies for regulatory submissions.